Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 562 M508 M522 M631 M582 M 2.24 B Research & development ————— — Operating income 945 M1.33 B1.7 B934 M1.16 B 5.13 B Non-Operating Income, Total -210 M-115 M-123 M74 M-6 M -170 M Interest expense, net of interest capitalized 249 M228 M248 M267 M278 M 1.02 B Non-Operating Income, excl. Interest Expenses -199 M-109 M-87 M-247 M-286 M -729 M Unusual income/expense -11 M-6 M-36 M54 M2 M 14 M Pretax income 534 M1.09 B1.49 B4.47 B976 M 8.03 B Equity in earnings 48 M107 M158 M101 M84 M 450 M Taxes -1 M5 M11 M3 M26 M 45 M Non-controlling/minority interest 6 M5 M4 M8 M8 M 25 M After tax other income/expense ————— — Net income before discontinued operations 730 M1.21 B1.57 B753 M941 M 4.48 B Discontinued operations ————— — Net income 730 M1.21 B1.57 B753 M941 M 4.48 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 745 M1.21 B1.57 B753 M941 M 4.48 B Basic earnings per share (Basic EPS) 2.714.455.792.83.49 16.53 Diluted earnings per share (Diluted EPS) 2.74.415.742.763.48 16.39 Average basic shares outstanding 269 M272 M272 M271 M270 M — Diluted shares outstanding 276 M275 M274 M274 M271 M — EBITDA 970 M1.35 B1.73 B957 M1.22 B 5.26 B EBIT 946 M1.33 B1.7 B932 M1.16 B 5.13 B Cost of revenue 2.08 B2.28 B2.48 B2.24 B2.25 B 9.25 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 24 M24 M27 M25 M53 M 129 M